part2

Documents about part2

• STIX(TM) Version 2.0 (2017-07-20)#600903OASIS Open
• OData Version 4.01 (2020-04-24)#600729OASIS Open
• OSLC Core Version 3.0 (2017-04-05)#600769OASIS Open
• STIX(TM) Version 1.2.1 (2016-05-06)#600888OASIS Open
• TAXII(TM) Version 1.1.1 (2016-05-06)#600913OASIS Open
• Akoma Ntoso Version 1.0 (2018-08-30)#600534OASIS Open
• S-RAMP Version 1.0 (2013-12-24)#600826OASIS Open
• Open Document Format for Office Applications (OpenDocument) Version 1.2 (2011-09-30)#600736OASIS Open
• OASIS ebXML Messaging Services Version 3.0: Part 2, Advanced Features (2011-05-20)#600715OASIS Open
• OSLC Change Management Version 3.0 (2018-06-09)#600758OASIS Open
• OSLC Change Management Version 3.0 (2018-08-25)#600760OASIS Open
• Darwin Information Typing Architecture (DITA) v1.3 (2015-12-18)#600592OASIS Open
• OSLC Architecture Management Version 2.1 (2018-10-10)#600753OASIS Open
• OSLC Requirements Management Version 2.1 (2018-08-25)#600791OASIS Open
• Open Document Format for Office Applications (OpenDocument) Version 1.3 (2019-12-26)#600739OASIS Open
• Open Document Format for Office Applications (OpenDocument) Version 1.3 (2020-10-30)#600743OASIS Open
• Open Document Format for Office Applications (OpenDocument) Version 1.3 (2021-04-27)#600747OASIS Open
• Akoma Ntoso Version 2.0 Part 2: Specifications of AKN 3.1 (2026-10-02)#1330178OASIS Open
• The mind-body problem(s) in Descartes’ “Meditations” and Husserl’s “Crisis” (Part2)#748017PhilArchive
• Music & MEmory: A Pragmatic TRial for Nursing Home Residents With ALzheimer's Disease (METRIcAL)_part2#882672ClinicalTrials.gov
• (MIST2)-Part2: AEs Following DC Care at DC Teaching Clinic: Electronic#1320054ClinicalTrials.gov
• Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2)#1085615ClinicalTrials.gov
• MAP-IO (Marion Dusfresne Atmospheric Program - Indian Ocean) flow cytometry_part2#277967SEANOE
• A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell Malignancies#982716ClinicalTrials.gov
• The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV; part2#1101394ClinicalTrials.gov